オーソバイオロジクス市場規模、シェア、成長分析、製品タイプ別、タイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

オーソバイオロジクスの世界市場規模は、2023年に83億米ドルと評価され、2024年の87億8,000万米ドルから2032年には137億9,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.8％で成長する見通しです。

オーソバイオロジクス市場は、筋骨格系疾患の治癒を促進する製品を包含しており、再生医療の進歩、高齢化、整形外科手術の増加によって大きな成長が見込まれています。主な製品には、幹細胞、骨移植片、PRP（血漿-豊富血小板）療法などがあります。しかし、厳しい規制当局の承認、標準化の欠如、高額な治療費といった課題が、市場拡大の妨げになる可能性があります。このような障害にもかかわらず、この分野は、応用機会の急増、研究開発努力の増加、個別化医療への傾向の高まりにより、盛んになることが予想されます。その結果、市場情勢力学は予測期間を通じて顕著な成長を遂げることが予想され、運動器の健康のための治療オプションにおけるダイナミックで進化する状況を反映しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

オーソバイオロジクス市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 脱灰骨基質（DBM）
• 同種移植
• 骨形成タンパク質（BMP）
• 関節内補充療法
• 合成骨代替物
• 幹細胞療法

オーソバイオロジクス市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 膝
• 足首
• ヒップ
• 手首と肩
• 脊椎
• その他

オーソバイオロジクス市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 変形性関節症と変形性関節症
• 脊椎固定術
• 骨折回復
• 軟部組織損傷
• 顎顔面と歯科用途

オーソバイオロジクス市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院と外来センター
• 調査・学術機関
• 歯科医院

オーソバイオロジクス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Stryker Corporation（USA）
• Medtronic plc（Ireland）
• Zimmer Biomet Holdings, Inc.（USA）
• DePuy Synthes（Johnson & Johnson）（USA）
• Bioventus LLC（USA）
• Arthrex, Inc.（USA）
• NuVasive, Inc.（USA）
• Orthofix International N.V.（Netherlands）
• Globus Medical, Inc.（USA）
• Kuros Biosciences AG（Switzerland）
• Xtant Medical Holdings, Inc.（USA）
• Harvest Technologies Corporation（USA）
• Wright Medical Group N.V.（Netherlands）
• Smith & Nephew plc（UK）
• Bone Biologics Corp.（USA）
• Sano Orthopedics（USA）

結論と提言

Global Orthobiologics Market size was valued at USD 8.3 billion in 2023 and is poised to grow from USD 8.78 billion in 2024 to USD 13.79 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The orthobiologics market, encompassing products that enhance the healing of musculoskeletal conditions, is poised for significant growth driven by advancements in regenerative medicine, an aging population, and increasing orthopedic procedures. Key offerings include stem cells, bone grafts, and PRP (plasma-rich-platelet) therapies. However, challenges such as stringent regulatory approvals, lack of standardization, and high treatment costs may hinder market expansion. Despite these obstacles, the sector is set to flourish due to burgeoning opportunities in applications, increased research and development efforts, and a rising trend towards personalized medicine. As a result, the orthobiologics market is expected to experience notable growth through the forecast period, reflecting a dynamic and evolving landscape in treatment options for musculoskeletal health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthobiologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Orthobiologics Market Segments Analysis

Global Orthobiologics Market is segmented by Product Type, Type, Application, End-user and region. Based on Product Type, the market is segmented into Demineralized Bone Matrix (DBM), Allograft, Bone morphogenetic protein (BMP), Viscosupplementation, Synthetic bone substitutes and Stem cell therapy. Based on Type, the market is segmented into Knee, Ankle, Hip, Wrist & Shoulder, Spine and Others. Based on Application, the market is segmented into Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries and Maxillofacial & Dental Applications. Based on End-user, the market is segmented into Hospitals & Ambulatory Centers, Research & Academic Institute and Dental Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Orthobiologics Market

The global orthobiologics market is significantly driven by advancements in modern technologies and research and development efforts. Innovations in platelet-rich plasma (PRP), stem cell therapies, and various related techniques are enhancing the availability, access, and effectiveness of orthobiologics, thereby fueling market expansion. Furthermore, ongoing research and clinical trials are paving the way for the introduction of new treatment methods and products. These innovations not only promote faster healing but also contribute to better overall recovery outcomes, solidifying the positive trajectory of the orthobiologics market and attracting increasing interest from both healthcare providers and patients.

Restraints in the Global Orthobiologics Market

The expansion of the global orthobiologics market faces significant challenges primarily due to the demand for comprehensive research and the variability of outcomes associated with these therapies. Although advancements and promising developments in this field are evident, the insufficiency of thorough clinical studies demonstrating the effectiveness of various orthobiologics may limit their acceptance among healthcare providers. Furthermore, the inconsistency in results observed across multiple studies can foster doubt regarding the efficacy of certain products, ultimately influencing their widespread adoption and usage within medical practices. As a result, these factors collectively pose a restraint on market growth.

Market Trends of the Global Orthobiologics Market

The Global Orthobiologics market is witnessing a notable trend towards the increased adoption of Platelet-Rich Plasma (PRP) treatments, driven by its efficacy in treating joint pain, soft tissue injuries, and enhancing post-surgical recovery. This regenerative application of PRP is gaining traction among healthcare professionals and patients alike, fueled by the growing focus on minimally invasive procedures. Furthermore, initiatives aimed at standardizing PRP preparation and administration protocols are enhancing its credibility and reliability, leading to improved outcomes. As a result, this trend is expected to bolster the overall market growth, positioning PRP as a pivotal component of modern orthobiologic therapies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Orthobiologics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Demineralized Bone Matrix (DBM)
• Allograft
• Bone morphogenetic protein (BMP)
• Viscosupplementation
• Synthetic bone substitutes
• Stem cell therapy

Global Orthobiologics Market Size by Type & CAGR (2025-2032)

• Market Overview
• Knee
• Ankle
• Hip
• Wrist & Shoulder
• Spine
• Others

Global Orthobiologics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Osteoarthritis & Degenerative Arthritis
• Spinal Fusion
• Fracture Recovery
• Soft Tissue Injuries
• Maxillofacial & Dental Applications

Global Orthobiologics Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals & Ambulatory Centers
• Research & Academic Institute
• Dental Clinics

Global Orthobiologics Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Application, End-user)
  • US
  • Canada
• Europe (Product Type, Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DePuy Synthes (Johnson & Johnson) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix International N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harvest Technologies Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wright Medical Group N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bone Biologics Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sano Orthopedics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations